XML 35 R22.htm IDEA: XBRL DOCUMENT v3.20.2
TDCC Consolidated Balance Sheets Parentheticals - USD ($)
$ in Millions
Jun. 30, 2020
Dec. 31, 2019
Cash and cash equivalents (variable interest entities restricted - 2020: $41; 2019: $37) $ 3,724 $ 2,367
Accounts Receivable, Allowance for Credit Loss, Current 48 45
Investments, Fair Value Disclosure 1,457 1,584
Net property (variable interest entities restricted - 2020: $284; 2019: $330) 20,618 20,996
Finite-Lived Intangible Assets, Accumulated Amortization 4,130 3,886
Long-term debt $ 16,288 $ 15,975
Common Stock, Shares, Issued 753,924,753 751,228,644
Common Stock, Shares Authorized 5,000,000,000 5,000,000,000
Common Stock, Par or Stated Value Per Share $ 0.01 $ 0.01
The Dow Chemical Company [Domain]    
Cash and cash equivalents (variable interest entities restricted - 2020: $41; 2019: $37) $ 3,724 $ 2,367
Accounts Receivable, Allowance for Credit Loss, Current 48 45
Net property (variable interest entities restricted - 2020: $284; 2019: $330) 20,618 20,996
Finite-Lived Intangible Assets, Accumulated Amortization 4,130 3,886
Long-term debt $ 16,288 $ 15,975
Common Stock, Shares, Issued 100 100
Common Stock, Shares Authorized 100 100
Common Stock, Par or Stated Value Per Share $ 0.01 $ 0.01
Variable Interest Entity, Primary Beneficiary [Member]    
Cash and cash equivalents (variable interest entities restricted - 2020: $41; 2019: $37) $ 41 $ 37
Net property (variable interest entities restricted - 2020: $284; 2019: $330) 284 330
Long-term debt $ 20 $ 34